Heska - 24 Year Stock Price History | HSKA

Historical daily share price chart and data for Heska since 1997 adjusted for splits. The latest closing stock price for Heska as of October 27, 2021 is 225.06.
  • The all-time high Heska stock closing price was 274.20 on August 24, 2021.
  • The Heska 52-week high stock price is 275.94, which is 22.6% above the current share price.
  • The Heska 52-week low stock price is 110.90, which is 50.7% below the current share price.
  • The average Heska stock price for the last 52 weeks is 199.28.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Heska Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 213.4997 143.9300 274.2000 143.9300 225.0600 54.52%
2020 97.8642 97.0100 151.1800 52.1700 145.6500 51.81%
2019 82.3959 90.5600 99.3400 64.1700 95.9400 11.43%
2018 92.7229 79.7500 113.3100 58.3600 86.1000 7.34%
2017 92.7294 71.5500 110.2400 71.5500 80.2100 12.03%
2016 44.5886 36.9600 72.8500 27.0500 71.6000 85.11%
2015 29.0280 18.0300 39.7600 16.3200 38.6800 113.35%
2014 11.9812 8.7300 18.1300 8.6300 18.1300 107.91%
2013 7.4188 8.2800 9.3000 5.1800 8.7200 7.65%
2012 9.7663 7.3500 12.8400 7.0500 8.1000 10.96%
2011 7.6432 4.8410 10.1900 4.6610 7.3000 47.18%
2010 6.1338 5.8000 9.6990 4.1500 4.9600 -5.97%
2009 3.7369 2.4490 5.9500 1.7000 5.2750 110.92%
2008 11.0439 21.0000 21.0000 1.8100 2.5010 -86.33%
2007 20.1042 17.2000 29.0000 15.6000 18.3000 8.93%
2006 13.9996 13.5000 18.6000 10.1000 16.8000 27.27%
2005 9.3256 11.8000 13.5000 5.6000 13.2000 12.92%
2004 17.8213 23.0000 32.4000 10.0000 11.6900 -49.15%
2003 14.9321 3.8000 34.8000 3.4000 22.9900 556.86%
2002 6.8878 11.0000 13.5000 3.0000 3.5000 -65.00%
2001 10.4333 7.5000 14.6900 5.3000 10.0000 45.45%
2000 25.8963 27.5000 53.1300 6.8750 6.8750 -69.44%
1999 32.5702 42.5000 58.7500 15.6300 22.5000 -49.30%
1998 98.2546 122.5000 165.0000 32.5000 44.3800 -64.15%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.448B $0.197B
Heska Corporation sells advanced veterinary diagnostic and specialty products. Heska's state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The Company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled support to veterinarians.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86